DRAGARWQBSEDr Agarwals Eye Hospital Ltd-$· Healthcare ServicesHighNeutral
Announced Thu, 2 Jul, 2026 · 21:46 IST

NCLT shareholders approve Dr Agarwal's Eye Hospital amalgamation scheme

Nclt Scheme FiledStrategic Transactions View source PDFExplain this filing

DRAGARWQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.5%Reaction day
₹5035.00
prior close
₹5035.50
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.3%-0.1% vs market
Hospital peers, median of 23sector+0.4%-0.9% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.9 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.7
10m
+2.5
15m
+1.3
30m
+1.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.5-0.3-0.1+0.4-0.9
Next day
-0.7-0.1-0.6+0.3-1.0
2d
-0.7-0.8+0.1-0.4-0.3
3d
-2.3-2.8+0.5-2.9+0.6
4d
-0.3-1.0+0.7-0.6+0.3
5d
-3.4+0.4-3.8-0.1-3.3
1w
-0.2-0.5+0.3-1.6+1.4
15d
-0.3-1.9+1.6-2.0+1.7
1m
+0.3+0.4-0.2-1.9+2.1
2m
+6.4+3.5+2.9-1.2+7.6
3m
+4.3+2.0+2.3-9.4+13.6
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NCLT convened meeting on July 2, 2026, where equity shareholders of Dr Agarwal's Eye Hospital approved the Scheme of Amalgamation with Dr Agarwal's Health Care Limited. Of about 44.49 lakh votes cast, 89.86 percent (around 39.98 lakh) voted in favor and 10.14 percent (around 4.51 lakh) voted against. Promoters voted nearly 100 percent in favor. The scheme still needs NCLT sanction and other regulatory clearances before becoming effective.

Likely market impact

Amalgamation clears shareholder hurdle; needs NCLT sanction and other approvals before taking effect, streamlining the group structure.